This report contains market size and forecasts of Tenofovir Disoproxil Fumarate in global, including the following market information:
Global Tenofovir Disoproxil Fumarate Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Tenofovir Disoproxil Fumarate Market Sales, 2017-2022, 2023-2028, (K Pcs)
Global top five Tenofovir Disoproxil Fumarate companies in 2021 (%)
The global Tenofovir Disoproxil Fumarate market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
30 Pcs/Box Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Tenofovir Disoproxil Fumarate include Glaxo SmithKline, Gilead PHARMACARE, Chengdu Brilliant Pharmaceutical, CHIA TAI TIANQING (CTTQ) Pharmaceutical, Anhui Biochem Pharmaceutical, Qilu Pharmaceutical, Cipla, Zydus Cadila and Dr Reddy's Laboratories, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Tenofovir Disoproxil Fumarate manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Tenofovir Disoproxil Fumarate Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Tenofovir Disoproxil Fumarate Market Segment Percentages, by Type, 2021 (%)
30 Pcs/Box
10 Pcs/Box
Global Tenofovir Disoproxil Fumarate Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Tenofovir Disoproxil Fumarate Market Segment Percentages, by Application, 2021 (%)
HIV-1 Infection
Chronic Hepatitis
Other
Global Tenofovir Disoproxil Fumarate Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Tenofovir Disoproxil Fumarate Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Tenofovir Disoproxil Fumarate revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Tenofovir Disoproxil Fumarate revenues share in global market, 2021 (%)
Key companies Tenofovir Disoproxil Fumarate sales in global market, 2017-2022 (Estimated), (K Pcs)
Key companies Tenofovir Disoproxil Fumarate sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Glaxo SmithKline
Gilead PHARMACARE
Chengdu Brilliant Pharmaceutical
CHIA TAI TIANQING (CTTQ) Pharmaceutical
Anhui Biochem Pharmaceutical
Qilu Pharmaceutical
Cipla
Zydus Cadila
Dr Reddy's Laboratories
Mylan Pharmaceuticals
Natco Pharma
Emcure Pharmaceuticals
Torrent Pharmaceuticals
Wockhardt Ltd
Hetero Drugs
Abbott